---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-028236"
form_type: "8-K"
ticker: "XRN"
cik: "0001533615"
company_name: "Chiron Real Estate Inc."
filed_at: "2024-02-27T23:59:59+00:00"
generated_at: "2026-06-05T11:45:13.125817+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Global Medical REIT posts Q4 net loss of $0.8M; full-year AFFO $0.91/share, leverage down to 43.6%

## Summary
- Q4 net loss attributable to common stockholders of $0.8M ($0.01 diluted loss per share), vs net income $0.4M in Q4 2022.
- Q4 FFO $13.3M ($0.19/share), down from $15.5M ($0.22/share) YoY; AFFO $15.9M ($0.23/share) vs $16.5M ($0.24/share) YoY.
- Total revenue $33.0M, down 9.2% YoY, due to dispositions and $1.1M rent reserve recognized.
- Full-year 2023 dispositions generated $80.5M gross proceeds; leverage reduced to 43.6% from 47.6% at year-end 2022.
- Portfolio 96.5% occupied; acquisition pipeline $95M-$110M for 2024; no ATM issuance in 2023 or YTD 2024.

## SEC filing metadata
- accession: 0001104659-24-028236
- form_type: 8-K
- ticker: XRN
- cik: 0001533615
- company_name: Chiron Real Estate Inc.
- filed_at: 2024-02-27T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1533615/000110465924028236/0001104659-24-028236-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1533615/000110465924028236/tm247387d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-028236
- JSON: https://secwatch.observer/filing/0001104659-24-028236.json
- Plain text: https://secwatch.observer/filing/0001104659-24-028236.txt

## Key facts
- Earnings Releases
  Chiron Real Estate Inc. reported year ended December 31, 2023 results: net income 14.8 million, EPS 0.23.
  - Period: year ended December 31, 2023
  - Net income: 14.8 million
  - EPS: 0.23
  - Result: reported results
  source text: Net income attributable to common stockholders was $14.8 million, or $0.23 per diluted share
  evidence_url: https://www.sec.gov/Archives/edgar/data/1533615/000110465924028236/0001104659-24-028236-index.htm
- Earnings Releases
  Chiron Real Estate Inc. reported three months ended December 31, 2023 results: revenue 33.0 million, net income -0.8 million, EPS -0.01.
  - Period: three months ended December 31, 2023
  - Revenue: 33.0 million
  - Net income: -0.8 million
  - EPS: -0.01
  - Result: reported results
  source text: Total revenue decreased 9.2% year-over-year to $33.0 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1533615/000110465924028236/0001104659-24-028236-index.htm
- Earnings Releases
  Chiron Real Estate Inc. reported three months ended December 31, 2023 results: revenue 33.0 million, net income -0.8 million, EPS -0.01.
  - Period: three months ended December 31, 2023
  - Revenue: 33.0 million
  - Net income: -0.8 million
  - EPS: -0.01
  - Result: reported results
  source text: or $0.23 per share and unit, as compared to $16.5 million, or $0.24 per share and unit, in the comparable prior year period. · Total revenue decreased 9.2% year-over-year to $33.0 million, primarily driven by the Company’s property dispositions completed during the first nine months of 2023, as well as the recognition of reserves for approximately $1.1 million of
  evidence_url: https://www.sec.gov/Archives/edgar/data/1533615/000110465924028236/0001104659-24-028236-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.